A scan picked up a spot on your kidney called an angiomyolipoma (AML). It is not cancer. Most are small, quiet, and never need a thing done to them. The one reason your urologist watches them is a small chance of bleeding in larger ones. Size guides the plan.
Kidney cancers almost never contain visible fat. When the scan shows fat in the lesion, that is usually all the proof needed.
A small share show too little fat to be sure. The next step may be MRI, a needle biopsy, or treating it as if it were a cancer.
The size of the lesion, the size of any aneurysm inside it, and whether the other kidney has one too.
On a disc or through your patient portal. Your urologist will want to look at the scan, not only the words on the page.
| Your AML | Usual plan for a sporadic AML |
|---|---|
| Under 4 cm, no symptoms, no large aneurysm | Watch with a repeat scan, then check every 1 to 2 years if stable. |
| 4 to 8 cm | A shared decision. Lean toward treatment if it is growing, causing symptoms, has a large aneurysm, or you are planning a pregnancy. |
| Over 8 cm | Treatment is usually recommended. Embolization is the most common first step. |
| Aneurysm larger than 5 mm inside the lesion | Lower the bar to treat, no matter the overall size. |
4 cm is the size where bleeding risk starts to climb in a measurable way. Above 4 cm, treatment goes on the table but does not happen automatically. A 3.9 cm and a 4.1 cm AML behave almost the same. Many small lesions just above 4 cm are still watched if they are stable and have no large aneurysm.
An interventional radiologist threads a small catheter to the artery feeding the lesion and blocks the flow. The AML shrinks over weeks. Usually one night in the hospital. A flu-like feeling for 3 to 7 days after is common.
Surgery to remove the lesion plus a thin rim of normal kidney, while keeping the rest. Used for select cases where the lesion is large and solid, or where the scan cannot fully rule out a kidney cancer.
A daily pill (everolimus, sirolimus) that shrinks AMLs by about 30 to 50 percent over 6 to 12 months. Mostly used for AMLs tied to tuberous sclerosis. Lesions tend to grow back if the pill is stopped.
Tuberous sclerosis complex (TSC) is a genetic condition. About 8 out of 10 people with TSC develop AMLs over a lifetime, often multiple and in both kidneys. Tell your urologist if you have TSC, more than one AML, AMLs in both kidneys, or a close relative with TSC. The plan often includes the daily mTOR pill, more frequent scans, and a referral to a TSC clinic.
Pregnancy can push an AML to grow or bleed. If your AML is 4 cm or larger, or has a visible aneurysm, bring it up with your urologist before you conceive.
Tell your urologist if you take or are starting a blood thinner. The reason it was prescribed usually still wins, but the AML is part of the conversation.
For a small stable AML, there are no activity limits. For a very large AML, your urologist may talk through high-impact sports.
If another doctor scans your belly and mentions the AML, send the report and images to your urologist. They will want to compare them with your earlier scans.
You have sudden severe pain in the flank or upper belly on the side of your known AML. You see heavy blood in your urine, especially with clots. You feel lightheaded or like you might pass out. These can be signs of a bleed. Tell the ER team you have a known angiomyolipoma.
About this information
This is general educational information, not medical advice. It gives a plain-language summary of a condition and its common tests and treatments. The summary is not complete and cannot cover every symptom, medication, side effect, or risk that may apply to you. It is not a substitute for the judgment of a licensed clinician who has examined you and knows your history.
Reading this does not create a doctor-patient relationship with WellPrept or with any clinician who reviewed it. Always talk with your own doctor or care team before you start, stop, or change any test, treatment, or medication. If you think you have a medical emergency, call your local emergency number now.
WellPrept does not endorse any specific test, treatment, or medication as safe or effective for you. To the fullest extent allowed by law, WellPrept and its reviewers make no warranties about this information and are not liable for any decision or action based on it.
© 2026 WellPrept, Inc. All rights reserved.